Overview

Compare the Effects of Remifentanil and Fentanyl on the Duration of Mechanical Ventilation of ICU Patients

Status:
Recruiting
Trial end date:
2022-03-31
Target enrollment:
Participant gender:
Summary
To verify whether remifentanil is more beneficial to reduce the duration of mechanical ventilation, shorten the interval from SBT to extubation, reduce the incidence of adverse events, reduce the workload of nursing staff, reduce the dosage of sedatives and ICU hospitalization costs, shorten the length of ICU hospitalization, and reduce the short-term mortality.
Phase:
Phase 4
Details
Lead Sponsor:
Capital Medical University
Treatments:
Fentanyl
Remifentanil